Lv51
1270 积分 2025-09-28 加入
Alternative Splicing of Secretin Receptor (SCTR) and Its Low Expression Drive the Occurrence of Pancreatic Ductal Adenocarcinoma
21天前
已完结
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
22天前
已完结
Trastuzumab rezetecan, a HER2-directed antibody–drug conjugate, in patients with advanced HER2-mutant non-small-cell lung cancer (HORIZON-Lung): phase 2 results from a multicentre, single-arm study
22天前
已完结
The Antibody–Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma
2个月前
已完结
IKS04, a CanAg-Targeting Antibody–Drug Conjugate with Pyrrolobenzodiazepine, Shows Enhanced Efficacy with Unconjugated Antibody Coadministration in Animal Models
2个月前
已完结
Research progress of DNA damage repair (DDR) and DDR inhibitors in tumor immunotherapy
3个月前
已完结
Selective elimination of human pluripotent stem cells by Anti-Dsg2 antibody-doxorubicin conjugates
3个月前
已完结
A Phase I Study of the Anti-CEACAM6 Antibody Tinurilimab (BAY 1834942) in Patients with Advanced Solid Tumors
3个月前
已完结
PF-08046032: A Novel, Investigational CD25-Directed Antibody–Drug Conjugate Optimized for Selective Depletion of Regulatory T Cells in Advanced Malignant Tumors
3个月前
已完结
Valency of HER2 Targeting Antibodies Influences Tumor Cell Internalization and Penetration
3个月前
已完结
皖公网安备34019202002308
